Company: TBPH
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001104659-25-033819
Chunk: 73

Company: Theravance Biopharma, Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 73
---
) 111,120 shares subject to options exercisable within 60 days of March 21, 2025 and (ii) 10,537 RSUs subject to release within 60 days of March 21, 2025. (17) Includes an aggregate of (i) 1,229,404 shares subject to options exercisable within 60 days of March 21, 2025, and (ii) 173,294 RSUs and/or PSUs subject to release within 60 days of March 21, 2025. 47

TABLE OF CONTENTS

EQUITY COMPENSATION PLAN INFORMATION The following table provides information as of December 31, 2024 with respect to our ordinary shares that may be issued under our existing equity compensation plans.

| Plan Category                                          | ​ | ​ | Number of Securitiesto be Issued UponExercise ofOutstanding Options,Warrants and Rights |   |              |   | ​ | ​ | Weighted AverageExercise Price ofOutstandingOptions, Warrantsand Rights ($) |   |          |   | ​ | ​ | Number of SecuritiesRemaining Availablefor Future IssuanceUnder EquityCompensation Plans |   |              |   | ​ |
| Equity compensation plans approved by shareholders     | ​ | ​ | ​                                                                                       | ​ | 5,784,655(1) | ​ | ​ | ​ | ​                                                                           | ​ | 15.53(3) | ​ | ​ | ​ | ​                                                                                        | ​ | 7,874,007(4) | ​ | ​ |
| Equity compensation plans not approved by shareholders | ​ | ​ | ​                                                                                       | ​ |    67,740(2) | ​ | ​ | ​ | ​                                                                           | ​ |    15.52 | ​ | ​ | ​ | ​                                                                                        | ​ |         —(5) | ​ | ​ |
| Total                                                  | ​ | ​ | ​                                                                                       | ​ |    5,852,395 | ​ | ​ | ​ | ​                                                                           | ​ |    15.53 | ​ | ​ | ​ | ​                                                                                        | ​ |    7,874,007 | ​ | ​ |

(1) Includes 1,829,168 shares issuable upon exercise of outstanding options and 3,955,487 shares issuable upon vesting of outstanding RSUs. (2) Consists entirely of shares issuable upon exercise of outstanding options. (3) Does not take into account outstanding